Omada Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by Omada Health, Inc. on June 16, 2026. The Company is an emerging growth company incorporated in Delaware, with its common stock trading on The Nasdaq Stock Market under the symbol OMDA.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Stockholders voted on two proposals at the Annual Meeting:
- Proposal One: Election of Class I Directors
- Sean Duffy: Elected with 18,540,089 votes for, 9,134,162 withheld, and 13,920,625 broker non-voters.
- Trevor Fetter: Elected with 18,538,042 votes for, 9,136,209 withheld, and 13,920,625 broker non-voters.
- Both directors will serve until the 2029 annual meeting.
- Proposal Two: Ratification of Independent Auditor
- Stockholders ratified the appointment of Deloitte & Touche LLP for the fiscal year ending December 31, 2026.
- Votes: 41,550,689 For, 16,905 Against, 27,282 Abstain.
- There were no broker non-votes on this proposal.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Key Facts for Investor Verification
- Sean Duffy and Trevor Fetter were successfully elected to the Board of Directors.
- Deloitte & Touche LLP was ratified as the independent auditor for fiscal year 2026.
- A significant portion of shares (approx. 13.9 million) were broker non-votes on the director election, indicating limited voting power for those specific shares on this proposal.
- The record date for the meeting was April 20, 2026.